Cancer: NICE (symptom based)- what s new November 2016

Similar documents
Recognition and Referral of Suspected Cancer - NICE guidance and local initiatives

Introduction. Please note the toolkit aims to share learning and good practice, but it is, of necessity, brief in nature.

Achieving earlier diagnosis of cancer in Lincolnshire. Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios

FIT for symptomatic patients. Facilitator name

East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres

Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West

Cancer Care Kenya Notes for General Practioners:

Haematological Cancer Suspected (Adults & Children)

Qcancer: symptom based approach to early diagnosis of cancer. Julia Hippisley-Cox, GP, Professor Epidemiology & Director ClinRisk Ltd

Cancer of Unknown Primary Service

Lung Cancer - Suspected

FREEDOM OF INFORMATION ACT 2000 Dudley CCG - Info re Prostate Cancer refferals etc.: RFI0430

Clinical Biochemistry Department City Hospital

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree

This information explains the advice about suspected cancer that is set out in NICE guideline NG12.

PRIORITIES AND CLINICAL EFFECTIVENESS FORUM

Dr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer Alliance

Transforming Cancer Services for London

Bronchiectasis in Adults - Suspected

GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012

Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis

Information for families with a slightly increased risk of bowel cancer. Family History of Bowel Cancer

Cancer of Unknown Primary (CUP) Protocol

Lung Cancer and the Cancer Alliance DR JAMES RAMSAY

Palliative Care Emergencies

South Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance

The York Faecal Calprotectin Care Pathway for use in primary care. James Turvill

Cancer Cascade Workshop. DoubleTree by Hilton, Bristol 11 th May 2017

There are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway.

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...

West Midlands Sarcoma Advisory Group

Early Diagnosis: Serious but non-specific symptom pathway

THAMES VALLEY AUDIT OF PATIENTS DIAGNOSED WITH CANCER FOLLOWING AN EMERGENCY PRESENTATION

Gynaecological cancers. Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist

Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography

Urgent referral for suspected cancer in Scotland

Prescribing Framework for Methotrexate for Immunosuppression in ADULTS

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

Metastatic Spinal Cord Compression (MSCC) Clinical guidelines and pathway

Information for people without an increased risk of bowel cancer. Family History of Bowel Cancer

Cancer. University of Illinois at Chicago College of Nursing

Multidisciplinary Diagnostic Centre (MDC) based pathways for patients with non-specific but concerning symptoms

Pancreatic Cancer. Stats, facts and how things can improve. Let s drive earlier diagnosis

Vinorelbine (Oral) Oral Vinorelbine

Rapid referral toolkit

FLU CLINICS 2012 This year, the surgery will be opening on Saturday 13 TH and 20 th October PLEASE NOTE:

Referral guidelines for suspected cancer

A patient s guide to understanding. Cancer. Screening

Pancreatic Cancer. An overview for GPs. Let s drive earlier diagnosis. Pancreatic Cancer Action All Rights Reserved

When to Refer for OGD and the Work Up of Upper GI Malignancies

Brain and Central Nervous System Cancers

1. What is fulvestrant?

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care

6 UROLOGICAL CANCERS. 6.1 Key Points

SOME USEFUL THINGS TO KNOW ABOUT HEAD AND NECK CANCER IN 2016

Healthcare Improvement Scotland First published May 2014

Childhood Cancer. Dr Sarah Taaffe. Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session

Dr Greg Frazer. Respiratory Physician Christchurch Hospital Christchurch. 15:10-15:35 Primary and Secondary Healthcare Interface Supported by:

Leeds: Early Diagnosis Project updates

Information leaflet for women with an increased lifetime risk of breast and ovarian cancer. Hereditary Breast and Ovarian Cancer (HBOC)

Gynaecology Cancer Red Flags. Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017

Referral guidelines for suspected cancer

Improving diagnostic pathways for patients with vague symptoms

Gemcitabine and Cisplatin (urology)

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

9/13/2017. Highgate Private Hospital & Whittington Health NHS Trust. London Cancer Urology Guidelines for Target Referrals. Urological Cancer Groups

GI cancer. Sharan Pobbathi Rumina Önaç

Philippine Cancer Society Forum: Cancer can be cured!

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

No. 2 - Persistent Pain or Discomfort in Any Body Area

SIGNS, SYMPTOMS AND SCREENING GUIDELINES

Alectinib (Alecensa ) Alectinib (Alecensa )

NICE Guidance. Suspected Cancer in Adults COLORECTAL (2WW)

Cancer Facts for People Over 50

RAISING THE AWARENESS OF GYNAECOLOGICAL CANCER. Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015.

CANCER. Mrs. Davis Health Education

PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE

Identification and early detection of cancer patients in primary care Marcela Ewing MD, PhD Regionalt Cancercentrum väst Gothenburg Sweden

Temozolomide Chemotherapy -

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

NEW GYN PATIENT HISTORY FORM (OB PATIENTS, please DO NOT USE THIS FORM. Thanks.)

Methotrexate for inflammatory bowel disease: what you need to know

The treatment is given every 3 weeks for 6 to 8 cycles.

Oral cyclophosphamide in ovarian cancer

Northumbria Healthcare NHS Foundation Trust. Laparoscopic Cholecystectomy. Issued by the Department of Upper Gastrointestinal Surgery

GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY

Brentuximab vedotin. Brentuximab vedotin

Vinblastine (Lymphoma)

Myeloma Haematology and Transplant Unit CTD1

Gemcitabine and carboplatin (Lung)

Acute Oncology Induction Training Specification

North Trent Cancer Network. Referral Guidelines, Head & Neck Cancer (including Thyroid), for Primary Care Practitioners

Epirubicin. Epirubicin

Patient Information Leaflet Number: CC 041 v2

Be cancer aware Patient Information

Transcription:

Cancer: NICE (symptom based)- what s new November 2016 Dr Katy Gardner, Dr Cathy Hubbert, Macmillan GP Cancer Leads, Liverpool CCG See stalls for more information and local pathways (Cheshire & Merseyside)

COULD IT BE CANCER? Now 3% threshold

HISTORY AND EXAM INVESTIGATE REFER REVIEW SAFETY NET

SYMPTOMS: NICE recognises that: Patients present with symptoms /signs or combinations: BMJ /CRUK charts

Non site specific symptoms of concern: WEIGHT LOSS: many cancers APPETITE LOSS: remember lung and ovary DVT is back! Several cancers include: urogenital, breast, colorectal, lung, pancreas FATIGUE: FBC, Ca125, CXR -(40+ ever smoked/ asbestos)

INVESTIGATIONS: some highlights FBC for PLATELETS, WBC, ANAEMIA IRON STUDIES ELECTROPHORESIS and BJP Ca 125 CALCIUM (myeloma) GLUCOSE ( pancreas, endometrial) ULTRASOUND/CT URINE visible/non visible haematuria *Recurrent infection can be significant

RAISED PLATELETS: in up to 30% of some cancers: Lung: >40 consider CXR Upper GI: >55 naus/vom/wt loss/ dyspepsia/abd pain: consider OGD Endometrial: >55 haematuria/vag disch: consider US Consider age/other risks

Iron Deficiency Anaemia (IDA) New importance in NICE.. No cut-off threshold 60+ IDA: Refer 2ww <50 IDA + rectal bleeding: consider ref to lower GI >55 anaemia +abdo pain: consider OGD (upper GI cancer)

Ix for Myeloma Persistent bone pain: esp back pain, or unexplained fracture: do FBC, ESR, Ca 60+ with hypercalcaemia/ WBC: do electrophoresis and BJP within 48hr As well as myeloma think about bony secondaries

When to check CA125 (Females) Abdo/pelvic pain/distention (persistent) age 50 IBS symptoms age 50 Change in bowel symptoms Urine urgency (persistent) age 50 Examine patient! NICE: Do CA125/US BUT locally: do Ca125 first: If Ca125, arrange US abdo/pelvis: mark URGENT suspected ovarian cancer. Put CA125 result on form. Will have US within 2 weeks

When to request US CONSIDER -Routine: F 55, Vaginal discharge (new/ platelets/haematuria (endometrial) F 55 haematuria + anaemia or platelets or glucose (endomterial) (AS WELL AS 2ww urology if visible haematiuria) M Unexplained or persistent testicular symptoms (BUT possible urgent!) URGENT: unexplained lump increasing in size (sarcoma)

When to request urgent CXR OFFER: 40 ever smoked +1 unexplained symptom (2 if never smoked): Cough, fatigue, SOB, chest pain, weight loss, appetite loss Asbestos exposure + 1 of above CONSIDER: >40 persistent/ recurrent chest infection, finger clubbing, LN: supraclavicular or cervical, pleural disease, thrombocytosis (Suspicious CXR: straight to CT pathway in Liverpool )

When to request urgent OGD Dysphagia 55 + weight loss + one of : Upper abdominal pain/ reflux/ dyspepsia CONSIDER if Upper abdominal mass consistent with stomach cancer (BUT consider CT ) See stalls for local pathways

When to arrange routine OGD CONSIDER if >55 and: Dyspepsia: treatment resistant Anaemia (normo/micro) + upper abdominal pain Nausea or vomiting + any of: weight loss /reflux/dyspepsia/upper abdo pain Raised platelets + naus vom wt loss /reflux/dyspepsia/upper abdo pain Hematemesis (use clinical judgment!)

When to request urgent CT: (think pancreas) CONSIDER: 60 + weight loss + one of: diarrhoea, constipation, back pain, abdominal pain, nausea, vomiting, new onset diabetes. Straight to CT pathways at Aintree & RLBUHT- and St Helens and Knowsley (for weight loss/ vague symptoms that don t fit 2ww see handout)

Faecal Occult Blood FOB in NICE for: 50 unexplained abdo pain or weight loss < 60 change in bowel habit or IDA >60 with anaemia not nec IDA BUT may not be available locally -debate ongoing. So what can we do? Examine / do bloods. IDA -- to IDA clinic if available or colorectal Wt loss - see CT or does any other pathway fit? If you think FOB and sx don t fit other urgent pathways-consider 2 ww GI referral.

Weight loss (recap) plus: Ever smoked/ h/o asbestos- cough/ fatigue/ SOB / chest pain/ appetite loss- CXR Abdo pain/ rectal bleeding- lower GI Upper abdo pain/ reflux/ dyspepsia or raised platelets/ nausea/ vomit- OGD Diarrhoea/ abdo/ back pain/ n/ v/ constipation/ new onset DM- CT Splenomegaly/ lymphadenopathy- Haematology F esp 50+ Ca125- ovarian

Fatigue (recap) plus: 40 or > Ever smoked/h/o asbestos/ cogh/ weight loss/sob/ chest pain/ appetite loss CXR* Persistent unexplained and age FBC within 48 hrs F 50 or > wt loss, change in bowel habit- Ca 125 Remember to examine the patient! *can be normal in up to 20% lung Ca think CT

Children & Young Adults Refer within 48 hr: Abdo mass /enlarged abdo organ/ unexplained visible haematuria Refer within 2w: absent red reflex FBC (48h): unexplained bruising/bleeding/pallor/lymphadenopathy/ fever/ infection/ fatigue US (48h): lump unexplained/ increasing X ray (48h): bone pain/ swelling Consider Parental concern 19

Tumour Specific Pathways Most = broader e.g Colorectal o 50y: unexplained rectal bleed o 40y: weight loss and abdo pain Clinical judgement key encourage GPs to refer, consider, investigate Controversial: ENT clinicians keep persistent sore throat etc. and remember HPV Some Oral lesions advises dentist but not all have one so refer 2ry care

Tumour Specific Pathways Useful Tools -worth CPD time to familiarise and know where to look! Eg Macmillan, GP Update, BMJ/CRUK charts GP UpdateCancer course

NICE emphasises Communicate: Patient preferences Potential risk and benefits Explain: referred to cancer service (but most referred do not have cancer) Inform on possible diagnosis (benign & malignant) Where, when, what, who? Further information/written, support, language Patient friendly letter/ CRUK leaflet (see stalls)

NICE emphasises: Safetynet Responsibility for reviewing/acting on results of investigation. Keep pt under review Or: Explicitly pass on responsibility. Awareness false negatives (CXR and FOB) New symptom, patient concerned, recurs, persists or worsens. HAVE YOU GOT FIALSAFE SYSTESM IN PLACE?

LOCAL INITIATIVES include Colorectal Clinics AO Email advice pilot Direct to CT Brain MRI Ovarian 50+ pathway See stalls! Ask CRUK team

Acute Oncology- Is it Cancer? Email advice see stalls for full algorithm

Direct to CT Aintree/ RLBUHT(similar New NICE Plus Patient has symptoms which give GP high index of suspicion of cancer but History/examine/ usual investigations don t fit 2ww.. Any age pathway Whitson) See Handouts. NB on local Trusts

Brain -Direct to MR coming soon Adults with progressive, sub-acute loss of CNS function* NICE says do MRI New referral forms for Walton Neuro being prepared. (Criteria/contraindications: see CCG websites) *Now: If Direct MRI not available refer 2ww or ring Walton helpline (available through switchboard)

Ovarian pathway: F age 50+ Cheshire and Merseyside-see stalls

Risk assessment tools: (Macmillan/Qcancer. Now in Emis) For common cancers: Estimates lifetime risk of cancer Based on multiple risk factors *Does not align perfectly with NICE Down to clinical judgements/patient preferences We feel: Useful if person presents with symptoms and you are thinking cancer

Do 3 things! Examples 1. Safety-netting: ensure systems in place 2. RCGP/national cancer audit 3. SEA: www.rcgp.org.uk/clinical-andresearch/clinical-resources/cancer

For more information contact your primary care cancer team : Dr Katy Gardner katyagardner@btinternet.com Dr Cathy Hubbert cathy.hubbert@livgp.nhs.uk Dr Debbie Harvey Debbie.Harvey@southseftonccg.nhs.uk Dr Paul Morris Paul.Morris@knowsleyccg.nhs.uk Dr Graeme Allan graeme.allan@talk21.com Dr Hong Tseung hong.tseung@nhs.net Tomas Edge (CRUK) tomas.edge@cancer.org.uk Louise Roberts (CRUK) louise.roberts@cancer.org.uk